Atlas Trials

Real World Study on the Efficacy and Safety of Anti-HER2 Therapy

Clinical trial NCT05367739 · COMPLETED

Trial details

NCT number
NCT05367739
Sponsor
Hunan Cancer Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Breast NeoplasmsHER2-positive Breast Cancer
Start date
2020-06-01
Primary completion
2022-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.